Literature DB >> 10411218

Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference.

S Ueda1, K Yamaoka, T Nakagawa.   

Abstract

The effects of anaesthesia on intestinal drug absorption and hepatic first-pass metabolism in rats were investigated by observing the difference in the drug concentration between portal and systemic bloods. Oxacillin and pentobarbital were selected as a model drug and as an anaesthetic, respectively. Rats were divided into a conscious control group and an anaesthetized group. All rats were cannulated simultaneously in the portal vein and in the femoral artery, and oxacillin was orally administered after its intra-arterial injection (double dosing). For the anaesthetized group, pentobarbital was intrasubcutaneously administered twice, first before intra-arterial injection and again before oral administration of oxacillin. The arterial blood alone was sampled from the cannula in the femoral artery before oral administration, whereas the arterial and portal bloods were simultaneously sampled from both cannulated sites after oral administration. Oxacillin concentrations in plasma were assayed by HPLC. The anaesthesia increased the absolute bioavailability (F), the mean absorption time (MAT) and the hepatic recovery ratio (F(H)), but caused little change in the local absorption ratio into the portal system (Fa) and the total clearance (CL). The hepatic clearance (CL(H)) was significantly decreased, resulting in an apparent small change in CL-CL(H) which is considered to be renal clearance. By this method, it was shown directly that an increase in F due to pentobarbital anaesthesia was attributable to the significant increase in F(H). It is expected that the method is useful not only to evaluate the effect of anaesthesia on the first-pass effect, but also to assess the effect of co-administration of drugs on first-pass metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411218     DOI: 10.1211/0022357991772682

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  A physiologic model for simulating gastrointestinal flow and drug absorption in rats.

Authors:  Stefan Willmann; Walter Schmitt; Jörg Keldenich; Jennifer B Dressman
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

2.  Pharmacokinetics and modeling of quercetin and metabolites.

Authors:  Xiao Chen; Ophelia Q P Yin; Zhong Zuo; Moses S S Chow
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

3.  Evaluation of capacity-limited first-pass effect through liver by three-points sampling in portal and hepatic veins and systemic artery.

Authors:  Shinya Ueda; Kiyoshi Yamaoka; Jyoji Yui; Akio Shigematsu; Terumichi Nakagawa
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

4.  Euthanasia method for mice in rapid time-course pulmonary pharmacokinetic studies.

Authors:  Adam R Schoell; Bruce R Heyde; Dana E Weir; Po-Chang Chiang; Yiding Hu; David K Tung
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-09       Impact factor: 1.232

5.  Effects of fructose-containing sweeteners on fructose intestinal, hepatic, and oral bioavailability in dual-catheterized rats.

Authors:  Leah R Villegas; Christopher J Rivard; Brandi Hunter; Zhiying You; Carlos Roncal; Melanie S Joy; MyPhuong T Le
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.